Cosmos Health宣布正式启动美国业务运营,携旗下Sky Premium Life品牌进军价值1640亿美元的营养保健品市场。
该公司预期将实现75%的毛利率水平,并产生强劲的现金流。其中,仅Noor胶原蛋白产品一项就预计能够创造超过1200万美元的年化收入。
此次进入美国市场标志着Cosmos Health在全球营养保健品领域的重要扩张步伐,该公司将通过Sky Premium Life品牌在这一高增长市场中寻求更大的发展机遇。
Cosmos Health宣布正式启动美国业务运营,携旗下Sky Premium Life品牌进军价值1640亿美元的营养保健品市场。
该公司预期将实现75%的毛利率水平,并产生强劲的现金流。其中,仅Noor胶原蛋白产品一项就预计能够创造超过1200万美元的年化收入。
此次进入美国市场标志着Cosmos Health在全球营养保健品领域的重要扩张步伐,该公司将通过Sky Premium Life品牌在这一高增长市场中寻求更大的发展机遇。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.